Author:
Zhang Chang-xiong,Cheng Ying,Liu Dao-zhou,Liu Miao,Cui Han,Zhang Bang-le,Mei Qi-bing,Zhou Si-yuan
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering
Reference39 articles.
1. Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016;13:193.
2. Gerczuk PZ, Kloner RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol. 2012;59:969.
3. Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B, et al. Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J. 2017;38:935.
4. Cung TT, Morel O, Cayla G, Rioufol G, Garciadorado D, Angoulvant D, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J med. 2015;373:1021.
5. Silva FSG, Costa CF, Marques RJ, Oliveira PJ, Pereira GC. Pharmacological targeting of the mitochondrial permeability transition pore for cardioprotection. Berlin: Springer; 2018.
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献